Biohaven Pharmaceutical (BHVN) - Earnings growth forecast for next year
Biohaven Ltd. is collaborating with scientific centers to develop cutting-edge treatments for ALS and migraine. The projected net profit trajectory confirms the effectiveness of the biopharmaceutical environment, where unique molecules minimize patient attrition. A robust patent shield for the protein degradation platform guarantees the stability of its position, and the current value is -0.50.
Comprehensive metric breakdowns and analytics for biohavenpharma.com (BHVN)
- stock quotes and analyst forecast:
- market capitalization indicators:
- book capitalization indicators:
- issuer credit burden and liquidity indicators:
- net income and valuation ratios data:
BHVN - Company Net Income|Projected Future Earnings Biohaven Ltd.|BHVN - Company Value to Net Income|Projected Price to Earnings Biohaven Ltd.|BHVN - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Biohaven|BHVN - Operating profit before amortization|Earnings per share for the last twelve months Biohaven|BHVN - Earnings per share for the last 12 months|Quarterly EPS earnings growth biohavenpharma.com|BHVN - Earnings per share growth rate in current year|Expected earnings per share growth for next year Biohaven Ltd.
Fundamental valuation:Biohaven Pharmaceutical, BHVN
This indicator measures the expected net income per share dynamics based on the balance of future operating revenues and R&D expenses. For Biohaven Ltd. (BHVN), this metric reflects the synergy efficiency of strategic alliances and M&A deals in neuropharmaceuticals, which allows for an assessment of the capitalization potential of new developments via the projected earnings per share growth for the next fiscal year on GURU.Markets.
Competing companies
Expected earnings per share growth for next year BIIB|Net earnings per share growth forecast for next year NBIX|Earnings growth forecast for next year RGC|AXSM - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year ACADIA Pharmaceuticals Inc. ACAD|XENE: Projected earnings per share growth rate for next year|VKTX: Expected earnings per share growth for next year|Expected earnings per share trend next year SUPN (Supernus Corp)|Catalyst Pharmaceuticals (CPRX) - Net earnings per share growth forecast for next year|DNLI (denalitherapeutics.com) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year HRMY|AMLX (Amylyx Pharmaceuticals Inc) - Projected earnings per share increase next year|Earnings growth forecast for next year TRVI|Praxis Corp - Projected earnings per share growth rate for next year|Anavex Life Sciences - Expected earnings per share growth for next year|Consensus forecast of earnings per share growth for next year ceribell.com (CBLL)|Prothena - Earnings growth forecast for next year|ALEC: Net earnings per share growth forecast for next year|ANNX: Earnings growth forecast for next year|Omeros - Expected earnings per share trend next year|Expected earnings per share growth for next year NGNE|Net earnings per share growth forecast for next year ACIU|Net earnings per share growth forecast for next year Voyager Therapeutics, Inc. (VYGR)|Neumora - Projected earnings per share growth rate for next year|Net earnings per share growth forecast for next year Scilex Holding Co. SCLX|TVGN: Projected earnings per share growth rate for next year|Alpha Cognition Corp - Earnings growth forecast for next year|Expected net earnings per share growth next year Cognition Therapeutics Inc.|IKT (Inhibikase Therapeutics, Inc.) - Expected earnings per share growth for next year|Cassava Sciences Inc (SAVA) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year Assertio Holdings|COYA: Expected earnings per share trend next year|Net earnings per share growth forecast for next year Vistagen Therapeutics (VTGN)|OVID - Expected net earnings per share growth next year|Earnings growth forecast for next year ABOS (Acumen Pharmaceuticals, Inc.)|CervoMed, Inc. - Net earnings per share growth forecast for next year|Alterity Therapeutics Ltd - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Clene Inc. CLNN|pepgen.com (PEPG) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Jupiter Neurosciences, Inc. (JUNS)|RLMD (Relmada Therapeutics, Inc.) - Earnings growth forecast for next year|ANVS: Expected earnings per share trend next year|Earnings growth forecast for next year GRCE|Earnings growth forecast for next year Firefly Neuro (AIFF)|Klotho Neurosciences - Expected earnings per share growth for next year|NeuroSense Therapeutics Ltd - Net earnings per share growth forecast for next year|Reviva Pharmaceuticals Holdings, Inc. - Earnings growth forecast for next year|Expected net earnings per share growth next year MetaVia Inc|NeurAxis, Inc (NRXS) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year HSDT|Expected earnings per share growth for next year PASG|NEUP: Expected earnings per share trend next year|Net earnings per share growth forecast for next year Minerva Neurosciences, Inc. (NERV)|Net earnings per share growth forecast for next year ATHA (Athira Pharma Inc)|Addex Therapeutics, Ltd. - Expected earnings per share growth for next year|Projected earnings per share increase next year ALZN (Alzamend Neuro Inc.)|Cyclerion - Earnings growth forecast for next year|PTIX (Protagenic Therapeutics) - Projected earnings per share growth rate for next year|KTTA (pasitheaclinics.com) - Expected earnings per share growth for next year|CRGT - Consensus forecast of earnings per share growth for next year|ATXI (Avenue Therapeutics, Inc) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year BCLI|Earnings growth forecast for next year CARA|CHRO (chromocell.com) - Expected earnings per share trend next year|Eliem Therapeutics Inc. - Expected earnings per share growth for next year|Intra-Cellular Therapies Inc. - Net earnings per share growth forecast for next year|LBPH - Net earnings per share growth forecast for next year|MRNS (Marinus Pharma) - Projected earnings per share growth rate for next year|NKGen Biotech, Inc. (NKGN) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year NRBO|SAGE (Sage Therapeutics) - Earnings growth forecast for next year|Expected net earnings per share growth next year Synaptogenix Inc. SNPX|Expected earnings per share growth for next year TRVN (Trevena, Inc)|Earnings growth forecast for next year vigilneuro.com (VIGL)|Net earnings per share growth forecast for next year Anew Medical WENA|Expected earnings per share trend next year CERE
